EAF•October 25, 2026 at 6:15 PM UTCMaterials

GrafTech Signals Price Uptick and Further Cost Cuts, but Structural Overhang Persists

Read source article

What happened

GrafTech disclosed that fourth-quarter realized prices are expected to rise by mid-single digits from the prior quarter, marking the first sequential increase after a prolonged decline. The company also announced the closure of its Monterrey plant, which is projected to save up to $25 million annually, reinforcing its cost-reduction efforts. These developments come after a period of intense pricing pressure and negative unit economics, where Q4 2025 realized price was around $4,000 per metric ton, still below cash cost of $4,019. While the projected price increase and additional cost savings could narrow the cash burn, they remain modest relative to the company's $104 million annual interest expense and require confirmation in actual results. Moreover, the closure of Monterrey may reduce capacity but does not address the core issue of global oversupply, particularly from China, that continues to pressure graphite electrode pricing.

Implication

The path to sustainable profitability remains uncertain even with the projected price increase and plant closure savings. GrafTech likely still operates near or below cash break-even per ton before interest, as a mid-single digit price rise from $4,000/MT only yields roughly $200/MT, still below or barely above cash costs depending on cost reductions. Unless the industry sees broader capacity rationalization and China export pressure eases, the company's leveraged equity remains a speculative bet on pricing stabilization. Investors should monitor key metrics: sequential realized price, cash COGS per metric ton, and free cash flow over the next two quarters. The thesis is not broken, but conviction should remain low until the improvement is proven over multiple quarters.

Thesis delta

New information suggests a potential inflection in pricing and additional cost cuts, which could modestly improve unit economics. However, the magnitude is insufficient to reverse negative free cash flow or reduce leverage; thesis shifts slightly positive but remains under a 'show me' status.

Confidence

Medium